title: Doubts raised over 'read-through' Duchenne drug mechanism.
authors.forename: Cormac
authors.initials: C
authors.lastname: Sheridan
mesh_terms: D004345:Drug Industry; D006801:Humans; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*; D010069:Oxadiazoles / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D010069:Oxadiazoles; C515878:ataluren
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3585-90
references.pmid: 19208811
references.citation: PLoS Biol. 2013;11(6):e1001593
references.pmid: 23824517
references.citation: Nat Methods. 2012 Oct;9(10):937
references.pmid: 23018994
references.citation: Nature. 2007 May 3;447(7140):87-91
references.pmid: 17450125
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4878-83
references.pmid: 20194791